Document text
Principal Investigator: DOUGLAS K OWENS
Organization: STANFORD UNIVERSITY
Fiscal Year: 2024
Award: $759,543
Funding agency: National Institute on Drug Abuse
risis of substance use in the US. In 2021, more than 107,000 overdose deaths occurred, setting yet another grim record. The substance use epidemic continues to threaten hard-fought gains in prevention and control of HIV and hepatitis C virus (HCV) and related diseases. Identifying the best approach to reduce HIV and HCV transmission stemming from the substance use epidemic is of critical public health importance.
In this extension to our MERIT award, our overall aims remain the same but we seek to extend and broaden our work in each of the aims in 3 key areas by: 1) developing new methods and conducting analyses that address health disparities; 2) incorporating social determinants of health in assessing barriers to program delivery and implementation and evaluating interventions to address those barriers; 3) expanding our work to encompass the intersecting syndemics of stimulant use, Covid-19, and other related conditions. We will:
1. Model the effect of the opioid and stimulant epidemic on transmission of HIV, HCV, and related diseases.
2. Model the epidemiologic and population impacts of individual strategies to prevent and mitigate the harms of opioid and stimulant use on HIV, HCV, and other disease-related outcomes.
3. Model the epidemiologic and population impact of portfolios of strategies to mitigate the harms of opioid and stimulant use on HIV, HCV, and other disease-related outcomes.
4. Model the impact of barriers (including social determinants of health) and enablers to implementation of effective strategies and portfolios of strategies to reduce the harms of opioid and stimulant use.
Our work will provide clinicians, policymakers, and community organizations with critically needed guidance about strategies to mitigate the consequences of opioid and stimulant use and improve quality of life and health equity for people with substance use disorder.
Terms: <AIDS><AIDS Virus><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Actiq><Address><Alaska Native group><Alaska Native individual><Alaska Native people><Alaska Native population><American Indian Population><American Indian group><American Indian individual><American Indian people><Area><Award><Black><Black race><COVID crisis><COVID epidemic><COVID pandemic><COVID-19><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 pandemic><COVID-19 period><COVID-19 public health crisis><COVID-19 transmission><COVID-19 virus transmission><COVID-19 years><CV-19><Cessation of life><Communities><Coronavirus Infectious Disease 2019><Death><Dimensions><Disease><Disease Outbreaks><Disorder><Drug abuse><Duragesic><Epidemic><Epidemiology><Equity><Ethnic Origin><Ethnicity><Fentanest><Fentanyl><Fentyl><Funding><Grant><Guidelines><HCV><HCV Transmission><HCV/HIV><HIV><HIV and HCV><HIV and hepatitis C><HIV-HCV><HIV/HCV><HIV/Hepatitis C><Harm Minimization><Harm Reduction><Health Promotion><Hepatitis C Transmission><Hepatitis C virus><Housing><Human Immunodeficiency Viruses><Incidence><Individual><Inequity><International><Intervention><Intervention Strategies><LAV-HTLV-III><Latine><Latinx><Length><Life Expectancy><Lymphadenopathy-Associated Virus><METH use><Measures><Methods><Modeling><Monitor><Morbidity><Morbidity - disease rate><NIDA><National Institute of Drug Abuse><National Institute on Drug Abuse><Opiates><Opioid><Outbreaks><Outcome><Overdose><Paper><Peer Review><Persons><Phentanyl><Policies><Policy Maker><Population><Prevalence><Preventative strategy><Prevention><Prevention strategy><Preventive strategy><Public Health><Publishing><QOL><Quality of life><Race><Races><Research Resources><Resources><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-CoV-2 transmission><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><Salutogenesis><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Stimulant><Substance Use Disorder><Transmission><Viral Diseases><Virus Diseases><Virus-HIV><Work><abuse of drugs><abuses drugs><barriers to implementation><community based organizations><community marginalization><community organizations><coronavirus disease 2019><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease 2019 transmission><coronavirus disease 2019 virus transmission><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><coronavirus infectious disease-19><disparity in health><distribute naloxone><epidemiologic><epidemiological><epidemiological model><fentanyl use><fighting><health disparity><health equity><hepatitis C virus transmission><high risk><implementation barriers><implementation challenges><improved><intervention delivery><interventional strategy><marginalized community><medication-assisted therapy><medication-assisted treatment><methamphetamine use><mortality><naloxone availability><naloxone dispensary><naloxone dispensation><naloxone dispensing><naloxone distribution><naloxone provision><opiate consumption><opiate crisis><opiate drug use><opiate intake><opiate use><opioid consumption><opioid crisis><opioid drug use><opioid epidemic><opioid intake><opioid use><overdose death><overdose fatalities><population health><prevent><preventing><programs><promoting health><provide naloxone><psychosocial><psychostimulant use><racial><racial background><racial origin><screening><screenings><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><severe acute respiratory syndrome coronavirus 2 transmission><social><social health determinants><socio-demographics><sociodemographics><stem><stimulant use><structural determinants><structural factors><substance use><substance use and disorder><substance using><syndemic><synergistic epidemic><transmission process><transmitted COVID-19><transmitted SARS-CoV-2><transmitted coronavirus disease 2019><transmitted severe acute respiratory syndrome coronavirus 2><use of stimulants><viral infection><virus infection><virus-induced disease>